Evaluation of the compaction properties of a solid dispersion of indomethacin with crospovidone by tableting process analyzer

Chemical and Pharmaceutical Bulletin

Volumn 53, Issue 7, 2005, Pages 759-763

  Shibata, Yusuke ^a   Fujii, Makiko ^a   Okada, Hideko ^a   Noda, Shinobu ^a   Kondoh, Masuo ^a   Watanabe, Yoshiteru ^a  

^a SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Compaction property; Crospovidone; Direct compression; Indomethacin; Solid dispersion; Tablet

Indexed keywords

CROSPOVIDONE; INDOMETACIN; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE;

ARTICLE; DISPERSION; DRUG FORMULATION; HARDNESS; PHYSICAL CHEMISTRY; PRESSURE; TABLET;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; EXCIPIENTS; INDOMETHACIN; POVIDONE; TABLETS;

EID: 24944550445     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.53.759     Document Type: Article

References (24)

1. Sekiguchi K., Obi N., Chem. Pharm. Bull., 9, 886-872 (1961).
2. Chiou W. L., Riegelman S., J. Pharm. Sci., 60, 1281-1302 (1971).
3. Ford J. L., Stewart A. F., Rubinstein M. K., J. Pharm. Pharmacol., 31, 726-729 (1979).
4. Serajuddin A. T. M., J. Pharm. Sci., 88, 1058-1066 (1999).
5. Leuner C., Dressman J., Eur. J. Pharm. Biopharm., 50, 47-60 (2000).
6. Fujii M., Okada H., Shibata Y., Teramachi H., Kondoh M., Watanabe Y., Int. J. Pharmaceut., 293, 145-153 (2005).
7. Kawakita K., Kagaku, 26, 149-150 (1956).
8. Kato K., Hattori Y., "The 15th Symposium on Particulate Preparations and Designs, Japan," Shiga, 1998, pp. 67-72.
9. Nonaka R., Yukawa J., "The 18th Symposium on Particulate Preparations and Designs, Japan," Aichi, 2001, pp. 103-104.
10. Nonaka R., Kato K., Okada K., "The 19th Symposium on Particulate Preparations and Designs, Japan," Fukuoka, 2002, pp. 78-79.
11. Visavarungroj N., Remon J. P., Int. J. Pharmaceut., 62, 125-131 (1990).
12. Shah A. C., Mlodozeniec A. R., J. Pharm. Sci., 66, 1377-1382 (1977).
13. Oya A., Nakai Y., Nagai E., Takei Y., Pharm. Tech. Japan, 5, 1199-1201 (1989).
14. Wadke D., Serajuddin A. T. M., Jacobson H., Preformulation testing, chapter in "Pharmaceutical Dosages Forms: Tablets Vol. 1," ed. by Lieberman H. A., Lachnman L., Schwartz J. B., Marcel Dekker, New York, 1990, pp. 1-74.
15. Regnarsson G., Holzer A. W., Sjogren J., Int. J. Pharmaceut., 3, 127-131 (1979).
16. Bessho S., Tomioka S., Ito S., Yakugaku Zasshi, 89, 599-606 (1969).
17. Doelker E., Massuelle D., Eur. J. Pharm. Biopharm., 58, 427-444 (2004).
18. Takeuchi H., Nagira S., Yamamoto H., Kawashima Y., Int. J. Pharmaceut., 274, 131-138 (2004).
19. Shotton E., Obiorah B. A., J. Pharm. Sci., 64, 1213-1216 (1975).
20. Ichibagase H., Uekama K., Odagiri M. (ed.), "Pharmaceutical Research and Development," Vol. 12, "Pharmaceutical Necessities 1," Hirokawa, Tokyo, 1990, pp. 156-177.
21. Naito S., Masui K., Shiraki T., J. Pharm. Sci., 66, 254-259 (1977).
22. Sugimori K., Mori S., Kawashima Y., Chem. Pharm. Bull., 37, 1064-1067 (1989).
23. Danjo K., Kamiya K., Otsuka A., Chem. Pharm. Bull., 41, 1423-1427 (1993).
24. Watanabe Y., Endo K., Koizumi K., Matsumoto M., Yakuzaigaku, 58, 147-154 (1998).